Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from BioNTech

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data

Here's a roundup of top developments in the biotech space over the last 24 hours.

Pfizer launches Omicron vaccine trial; UK reports highest daily deaths since February – as it happened

Pfizer launches Omicron vaccine trial; UK reports highest daily deaths since February – as it happened

Company hopes vaccine will be ready for approval by March; UK reports 439 deaths and more than nearly 95,000 cases

The Guardian - UK

A Bearish Sign Appears On BioNTech's Chart

A Bearish Sign Appears On BioNTech's Chart

If history is any guide, there may be trouble ahead for shares of BioNTech (NASDAQ:BNTX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

This Is What Whales Are Betting On BioNTech

A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades.

Where BioNTech Stands With Analysts

Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings:

1 … 6 7 8 9

People

Nicola Sturgeon

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

International Monetary Fund

Sierra Oncology

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

390,137 stories

142,515 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play